59
Views
0
CrossRef citations to date
0
Altmetric
SHORT REPORTS

The role of modifiable pre-pregnancy risk factors in preventing adverse fetal outcomes among women with type 1 and type 2 diabetes

, , , , &
Pages 1153-1157 | Received 20 May 2009, Published online: 19 Sep 2009

References

  • Evers IM, de Valk HW, Visser GH. Risk of complications of pregnancy in women with type 1 diabetes: nationwide prospective study in the Netherlands. BMJ. 2004; 328: 915
  • Jensen DM, Damm P, Moelsted-Pedersen L, Ovesen P, Westergaard JG, Moeller M, et al. Outcomes in type 1 diabetic pregnancies: a nationwide, population-based study. Diabetes Care. 2004; 27: 2819–23
  • Macintosh MCM, Fleming KM, Bailey JA, Doyle P, Modder J, Acolet D, et al. Perinatal mortality and congenital anomalies in babies of women with type 1 or type 2 diabetes in England, Wales, and Northern Ireland: population based study. BMJ. 2006; 333: 177
  • Inkster ME, Fahey TP, Donnan PT, Leese GP, Mires GJ, Murphy DJ. Poor glycated haemoglobin control and adverse pregnancy outcomes in type 1 and type 2 diabetes mellitus: systematic review of observational studies. BMC Pregnancy Childbirth. 2006; 6: 30
  • Workshop Report. Diabetes care and research in Europe: the Saint Vincent Declaration. Diabet Med. 1990;7:360.
  • Yang J, Cummings EA, O'Connell C, Jangaard K. Fetal and neonatal outcomes of diabetic pregnancies. Obstet Gynecol. 2006; 108: 644–50
  • Pearson, D, Kernaghan, D, Lee, R, Penney, G, on behalf of the Scottish Diabetes in Pregnancy Study Group. The relationship between pre-pregnancy care and early pregnancy loss, major congenital anomaly or perinatal death in type 1 diabetes mellitus. BJOG. 2007;114:104–7.
  • Hawthorne G, Irgens LM, Lie RT. Outcome of pregnancy in diabetic women in Northeast England and in Norway, –7. BMJ. ;321 1994; 2000: 730–1
  • Morris AD, Boyle DI, MacAlpine R, Emslie-Smith A, Jung RT, Newton RW, et al. The diabetes audit and research in Tayside Scotland (DARTS) study: electronic record linkage to create a diabetes register. BMJ. 1997; 315: 524–8
  • Scottish perinatal and infant mortality and morbidity report. 2007. Available online at:, , www.isd.scotland.org. accessed May 20, 2009
  • Santos Silva I, Higgins C, Swerdlow AJ, Laing SP, Slater SD, Pearson DWM, et al. Birthweight and other pregnancy outcomes in a cohort of women with pre-gestational insulin-treated diabetes mellitus, Scotland, –1995. Diabet Med. ;22 1979; 2005: 440–7
  • Miller E, Hare JW, Cloherty JP, Dunn PJ, Gleason RE, Soeldner JS, et al. Elevated maternal hemoglobin A1c in early pregnancy and major congenital anomalies in infants of diabetic mothers. NEJM. 1981; 304: 1331–4
  • Dokken B, Johnson D. The importance of reaching preconception targets for glycemic control in diabetic women. Arch Inter Med. 1998; 1581: 299–300
  • Nielsen GL, Sorensen HT, Nielsen PH, Sabroe S, Olsen J. Glycated hemoglobin as predictor of adverse fetal outcome in type 1 diabetic pregnancies. Acta Diabetol. 1997; 34: 217–22
  • Kerssen A, de Valk HW, Visser GH. Do HbA1c levels and the self-monitoring of blood glucose levels adequately reflect glycaemic control during pregnancy in women with type 1 diabetes mellitus?. Diabetologia. 2006; 49: 25–8

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.